who should take semaglutide for weight loss FDA Approves Oral Semaglutide: First GLP-1 Pill Semaglutide GLP-1 Medical Weight Loss

The FDA Wegovy prescribing information describes semaglutide as used with reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in eligible adults

It tends to upregulate genes involved in regeneration and downregulate those associated with inflammation or fibrosis

Those who produce less stomach acid, such as people over 50 or individuals taking acid-reducing medications, may not absorb B12 from food efficiently

While early clinical trials showed manageable side effects, post-marketing surveillance has revealed more severe complications that require closer scrutiny

A vial that looks clear and sterile can have 3050% reduced activity if it was shaken during mixing, stored above 8C for more than a few hours, or reconstituted with non-sterile water